Motley Fool Australia
  •  
  • Log Out
  • Menu
  1. Stocks
    2. /
  2. Rhythm Biosciences Ltd (ASX: RHY)
    3. /

Rhythm Biosciences Ltd (ASX: RHY) Share Price and News

Price

$0.06

Movement

0.003 (-4.76%)

As at 10 Jun - Closed (20 mins delayed)

52 Week Range

$0.042 - $0.14

 
1 Year Return

-14.29%

Rhythm Biosciences Ltd Chart and Price Data

2025
2025
2025
2025
$0.05
$0.10
$0.15
$0.05
$0.10
$0.15
$0.05
$0.10
$0.15
$0.05
$0.10
$0.15

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $17.90 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 284.08 million
Earnings per share -0.010
Dividend per share N/A
Year To Date Return -27.59%
Earnings Yield N/A
Franking -
Earnings Yield

N/A

Franking

-

Dividend per share

N/A

Year To Date Return

-27.59%

Shares Outstanding

284.08 million

Earnings per share

-0.010

Share Price

$0.06

Day Change

0.003 (-4.76%)

52 Week Range

$0.042 - $0.14

Yesterday's Close

$0.063

Today's Open

$0.062

Days Range

$0.058 - $0.062

Volume

452,883

Avg. Volume (1 month)

176,081

Turnover

$27,150

As at 10 Jun - Closed

    • Rhythm Biosciences Ltd (ASX: RHY)
    Latest News

    woman in lab coat conducting testing representing biotech
    Share Market News

    What is going on with the Rhythm (ASX:RHY) share price today?

    | Aaron Teboneras

    The Rhythm Biosciences Ltd (ASX: RHY) share price is recovering after slipping this morning despite announcing a positive update.

    Read more »

    ASX bank profit upgrade Red rocket and arrow boosting up a share price chart
    Share Market News

    The Rhythm (ASX:RHY) share price surges on cancer testing milestone

    | Kerry Sun

    The Rhythm Biosciences Ltd (ASX: RHY) share price has surged 6% higher on Tuesday as the company takes a step…

    Read more »

    Medical staff wear hero capes, indicting strong shar [price performace for healthcare shares
    Share Market News

    Which ASX healthcare shares saw the biggest gains in February?

    | Kerry Sun

    ASX healthcare shares struggled to make headway in February. Here are the 2 companies that managed to come out on…

    Read more »

    Share Market News

    What's happening with the Rhythm (ASX:RHY) share price today?

    | Aaron Teboneras

    The Rhythm Biosciences Ltd (ASX: RHY) share price is sinking today, despite announcing a positive update to its ColoSTAT trial…

    Read more »

    hand on touch screen lit up by a share price chart moving higher
    Share Market News

    Why the Rhythm (ASX:RHY) share price again reached a new all-time record today

    | Aaron Teboneras

    The Rhythm Biosciences Ltd (ASX: RHY) has risen to another all-time high record following the update on the initial manufacturing…

    Read more »

    medical asx share price represented by doctor giving thumbs up
    Share Market News

    Here's why the Rhythm (ASX:RHY) share price hit an all-time high today

    | Aaron Teboneras

    Shares in Rhythm Biosciences Ltd (ASX: RHY) are soaring higher during early-afternoon trade. This comes after the company announced it…

    Read more »

    Medical staff wear hero capes, indicting strong shar [price performace for healthcare shares
    Share Market News

    Rhythm Biosciences (ASX: RHY) share price soars 1300% in 6 months

    | Gretchen Kennedy

    The Rhythm Bioscience share price continues to push its way up. We take a closer look at what's driving the…

    Read more »

    Share Gainers

    Here's why the Rhythm Bioscience (ASX:RHY) share price is up 15% to a record high

    | James Mickleboro

    The Rhythm Biosciences Ltd (ASX:RHY) share price is on fire again on Tuesday and hit a new record high. Here's why...

    Read more »

    asx share price rise represented by red paper plane flying away from other white paper planes
    Share Market News

    Why the Rhythm Biosciences (ASX:RHY) share price jumped over 600% this year

    | Gretchen Kennedy

    The Rhythm Biosciences share price has soared over 600% this year. We take a closer look at what the company's…

    Read more »

    surging asx share price represented by piggy bank with rocket attached to it
    Share Market News

    The Rhythm (ASX:RHY) share price is surging 5% higher today. Here's why.

    | Aaron Teboneras

    The Rhythm Biosciences Ltd (ASX: RHY) share price has climbed 5% higher today following United States approval of a patent…

    Read more »

    asx share price increase represented by golden dollar sign rocketing out from white domes of lithium
    Share Gainers

    Why the Rhythm Biosciences (ASX:RHY) share price rocketed 28% to a record high

    | James Mickleboro

    The Rhythm Biosciences Ltd (ASX:RHY) share price rocketed 28% higher to a record high on Friday. Here's why...

    Read more »

    Man looking excitedly at ASX share price gains on computer screen against backdrop of streamers
    Share Gainers

    These small cap ASX shares delivered more than 100% returns in November

    | Lina Lim

    Here are the best performing small cap ASX shares across the mining and biotech sectors that more than doubled in…

    Read more »

    RHY ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    10th Jun 2025 2025-06-10T17:26:34 Change in substantial holding - Michelle WingYesNo5:26pm3428k
    2nd Jun 2025 2025-06-02T15:20:53 Cleansing NoticeYesNo3:20pm2366k
    2nd Jun 2025 2025-06-02T15:06:43 Application for quotation of securities - RHYYesNo3:06pm616k
    2nd Jun 2025 2025-06-02T09:07:56 Investor PresentationYesNo9:07am171.6M
    30th May 2025 2025-05-30T10:08:58 Proposed issue of securities - RHYYesNo10:08am515k
    26th May 2025 2025-05-26T08:53:45 ColoSTAT Beta kit verification and validation updateYesNo8:53am38.2M
    15th May 2025 2025-05-15T09:02:04 Breast Cancer Risk Study University of MelbourneYesNo9:02am2432k
    2nd May 2025 2025-05-02T12:45:57 Notification regarding unquoted securities - RHYYesNo12:45pm515k
    1st May 2025 2025-05-01T16:21:12 Proposed issue of securities - RHYYesNo4:21pm515k
    24th Apr 2025 2025-04-24T09:17:28 Quarterly Activities Report and Appendix 4C 31 March 2025YesNo9:17am10663k

    About Rhythm Biosciences Ltd

    Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. The company operates predominantly in one business and geographical segment which is the research and development of biosciences in Australia.

    RHY Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    06 Jun 2025 $0.06 $0.00 0.00% 64,239 $0.06 $0.06 $0.06
    05 Jun 2025 $0.06 $0.00 0.00% 53,779 $0.06 $0.06 $0.06
    04 Jun 2025 $0.06 $0.00 0.00% 269,207 $0.06 $0.06 $0.06
    03 Jun 2025 $0.06 $0.00 0.00% 18,895 $0.06 $0.06 $0.06
    02 Jun 2025 $0.06 $0.00 0.00% 235,041 $0.06 $0.06 $0.06
    30 May 2025 $0.07 $0.00 0.00% 265,006 $0.06 $0.07 $0.06
    29 May 2025 $0.07 $0.00 0.00% 121,153 $0.07 $0.07 $0.07
    28 May 2025 $0.06 $0.00 0.00% 17,695 $0.06 $0.06 $0.06
    27 May 2025 $0.07 $0.00 0.00% 453,736 $0.07 $0.07 $0.07
    26 May 2025 $0.07 $0.01 16.39% 520,074 $0.06 $0.07 $0.06
    23 May 2025 $0.06 $0.00 0.00% 111,294 $0.06 $0.06 $0.06
    22 May 2025 $0.06 $0.00 0.00% 47,036 $0.06 $0.06 $0.06
    21 May 2025 $0.06 $0.00 0.00% 85,661 $0.06 $0.06 $0.06
    20 May 2025 $0.06 $0.00 0.00% 150,000 $0.06 $0.06 $0.06
    19 May 2025 $0.06 $0.00 0.00% 11,129 $0.06 $0.06 $0.06
    16 May 2025 $0.06 $0.00 0.00% 21,341 $0.06 $0.06 $0.06
    15 May 2025 $0.06 $0.00 0.00% 44,304 $0.06 $0.06 $0.06
    14 May 2025 $0.06 $0.00 0.00% 898,520 $0.06 $0.06 $0.06
    13 May 2025 $0.06 $0.00 0.00% 47,501 $0.06 $0.06 $0.06
    12 May 2025 $0.06 $0.00 0.00% 86,011 $0.06 $0.06 $0.06

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    31 Jul 2024 Otto Buttula Expiry 1,342,500 $71,152
    Options expired.
    31 Jul 2024 Louis (Lou) Panaccio Expiry 85,000 $4,505
    Options expired.
    31 Jul 2024 Trevor Lockett Expiry 252,000 $13,356
    Options expired.
    14 Jun 2024 Otto Buttula Buy 600,000 $40,408
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Otto Leslie Steven Buttula Executive ChairmanExecutive Director Oct 2019
    Mr Buttula has had experience and success in investment research, funds management, information and biotechnologies and has held directorships in a number of public companies. Mr Buttula's executive experience includes co-founder and CEO and Managing Director of IWL Ltd, an online financial services company that listed on the ASX in 1999. Mr Buttula also founded and was Managing Director of Investors Mutual, prior to which he was a co-founder and director of Lonsdale Securities Ltd.
    Dr David Atkins Chief Executive OfficerManaging Director May 2024
    --
    Mr Gavin Fox-Smith Non-Executive Director Dec 2024
    Mr Fox-Smith has been a leader and champion of Medical Technology across Australia/NZ and Asia. He has also played lead Governance and Executive roles in Industry Bodies, Innovation Initiatives and Not for Profit Boards. Gavin is advocate for Gender Equality and Indigenous Engagement. His career spans over 35 years, previously holding the position of Managing Director Australia/NZ and Vice President Asia Pacific for Johnson & Johnson Medical Devices, Chair of the Medical Technology Association of Australia, Governor of American Chamber of Commerce, Co-Founder/Chair of Macquarie Park Business Coalition (in partnership with United Way) and Australian Co-Chair of the Health Technology Sector Group of the Australia/NZ Leadership Forum. Gavin is currently transitioning out of his executive CEO role at Omnigon, a private Australian company in the Ostomy Care market. He is currently, Chair of ANDHealth (Australias National Digital Health Initiative), Board Director for Bowel Cancer Australia and Board Director for SAN Foundation. Gavin is a member of the Champions of Change Coalition STEM/Health group and serves as Ambassador for Rotary Oceania Medical Aid for Children (ROMAC).
    Ms Andrea Steele Company SecretaryGeneral Counsel Feb 2022
    -
    Mr James Stephen Barrie Joint Company Secretary Dec 2023
    -
    Andrea Steele Company SecretaryGeneral Counsel
    -
    Guy Carisbrooke Financial Controller
    -
    James Stephen Barrie Joint Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Webinvest Pty Ltd 22,479,168 9.04%
    Newfound Investments Pty Ltd 13,905,407 5.59%
    Ferndale Securities Pty Ltd 10,300,000 4.14%
    HSBC Custody Nominees (Australia) Limited 9,269,796 3.73%
    Loumea Investment Pty Ltd 8,052,520 3.24%
    Northern Star Nominees Pty Ltd 7,380,000 2.97%
    Rojo Nero Capital Pty Ltd 4,213,751 1.70%
    Giokir Pty Ltd 3,661,470 1.47%
    Mr Hsien Michael Soo 3,305,403 1.33%
    Mr Mark Anthony Rogers & Mr Arthur Nicholas Veliss 3,000,000 1.21%
    DC & PC Holdings Pty Ltd 2,688,156 1.08%
    Commonwealth Scientific & Industrial Research Organisation 2,500,000 1.01%
    Ms Natalie Louise Patterson 2,477,083 1.00%
    E & W Nominee Pty Ltd 2,207,941 0.89%
    Mr Daniel Eddington & Mrs Julie Eddington 2,123,532 0.85%
    Mr Wei Feng & Mrs Jie Liu 2,050,215 0.82%
    Mrs Joan Margaret Molyneux & Mrs Wendy Anne Hutchison & Mr John Edward Hutchison 2,000,000 0.80%
    Ardroy Securities Pty Ltd 1,857,040 0.75%
    BNP Paribas Nominees Pty Ltd ACF Clearstream 1,775,214 0.71%
    Mrs Linda Jane Lockett & Dr Trevor John Lockett 1,678,300 0.68%

    Profile

    since

    Note